Van den Abbeele Pieter, Detzel Christopher, Rose Alexis, Deyaert Stef, Baudot Aurélien, Warner Christopher
Cryptobiotix SA, Technologiepark-Zwijnaarde 82, 9052 Ghent, Belgium.
Proliant Health & Biologicals, LLC., Des Moines, IA 50021, USA.
Microorganisms. 2023 Mar 4;11(3):659. doi: 10.3390/microorganisms11030659.
Serum-derived bovine immunoglobulins (SBI) exert health benefits mediated by their ability to bind microbial components, thereby preventing translocation and subsequent inflammation. While in vivo studies have shown that a fraction of SBI also reaches the colon, little is known about the impact of SBI on the dense colonic microbiota that has great potential to impact human health. This study, therefore, investigated the impact of three bovine plasma protein fractions (SBI, bovine plasma (BP) and albumin-enriched bovine plasma (ABP)) on the gut microbiota of six human adults using the novel ex vivo SIFR technology, recently demonstrated to generate predictive findings for clinical studies. When dosed at an equivalent of 5 g/day, all protein fractions significantly increased health-related metabolites-acetate, propionate, and butyrate. Upon simulating small intestinal absorption, SBI still markedly increased acetate and propionate, demonstrating that SBI is more resistant to small intestinal digestion and absorption compared to the other protein sources. Despite noticeable interindividual differences in microbiota composition among human adults, SBI consistently stimulated a narrow spectrum of gut microbes, which largely differed from the ones that are typically involved in carbohydrate fermentation. The SBI-fermenting consortium included and (correlating with acetate and propionate) along with and the butyrate-producing bacterium SS3/4 (correlating with butyrate). Overall, this study revealed that protein bovine fractions can contribute to health benefits by specifically modulating the human gut microbiota. While health benefits could follow from the production of SCFA, a broader range of protein-derived metabolites could also be produced. This study also confirms that the concept of prebiotics (substrates selectively utilized by host microorganisms conferring a health benefit) could go beyond the use of ingestible carbohydrates and extend to partially indigestible proteins.
血清来源的牛免疫球蛋白(SBI)通过其结合微生物成分的能力发挥健康益处,从而防止细菌移位及随后的炎症反应。虽然体内研究表明一部分SBI也能到达结肠,但关于SBI对密集的结肠微生物群的影响知之甚少,而结肠微生物群对人类健康具有巨大影响潜力。因此,本研究使用新型离体SIFR技术,研究了三种牛血浆蛋白组分(SBI、牛血浆(BP)和富含白蛋白的牛血浆(ABP))对六名成年人肠道微生物群的影响,最近已证明该技术可为临床研究产生预测性结果。当以相当于5克/天的剂量给药时,所有蛋白质组分均显著增加了与健康相关的代谢产物——乙酸盐、丙酸盐和丁酸盐。在模拟小肠吸收后,SBI仍能显著增加乙酸盐和丙酸盐,表明与其他蛋白质来源相比,SBI对小肠消化吸收更具抗性。尽管成年人之间的微生物群组成存在明显的个体差异,但SBI始终刺激了一小部分肠道微生物,这些微生物与通常参与碳水化合物发酵的微生物有很大不同。SBI发酵菌群包括与乙酸盐和丙酸盐相关的 和 ,以及与丁酸盐相关的产丁酸盐细菌SS3/4。总体而言,本研究表明牛蛋白组分可通过特异性调节人类肠道微生物群对健康有益。虽然短链脂肪酸的产生可能带来健康益处,但也可能产生更广泛的蛋白质衍生代谢产物。本研究还证实,益生元(被宿主微生物选择性利用并赋予健康益处的底物)的概念可能不仅限于可食用碳水化合物的使用,还可扩展到部分难以消化的蛋白质。